Aenova is significantly expanding its microbiology quality control (QC) laboratory at its Latina site. The project adds approximately 500 square meters of new laboratory space, bringing the total to a ...
Aenova has been ranked second best medium-sized pharmaceutical company in the prestigious evaluation by “Markt und Mittelstand” and “Die deutsche Wirtschaft.” The study evaluated 10,000 German compani ...
Under the mottos “Saving lives together. Helping leukemia patients,” Aenova launched a broad-based, group-wide registration campaign in early summer 2025 to help leukemia patients. Around 500,000 new ...
Aenova is expanding its site in Killorglin with a spray drying platform for amorphous solid dispersions (ASD) and inhalation powders. The brand-new laboratory- and pilot-scale equipment is aimed at de ...
Aenova relies on various innovative technologies to improve the oral bioavailability of poorly soluble pharmaceutical active ingredients. These include a new hot melt extrusion platform, which Aenova ...
In the Annual Report, Aenova once again reflects on an extremely successful fiscal year with a very strong performance. For the second consecutive year, the company has achieved its most successful re ...
Aenova is investing in a new cold chain warehouse at its sterile site in Latina, Italy. The cutting-edge facility marks a significant milestone in Aenova’s commitment to providing end-to-end integrate ...
Aenova CEO Jan Kengelbach recently granted an exclusive interview to the renowned business magazine Executive Forecast.
Jan Kengelbach provides insights into the strategy that will lead the company i ...
Aenova announces the launch of its innovative Aenovation™ program. This new initiative is designed to fast-track early development of pharmaceutical formulations, specifically addressing the critical ...
Aenova has published a new whitepaper addressing one of the pharmaceutical industry's most pressing R&D challenges: improving the bioavailability of poorly soluble drug candidates.Titled “Acceleration ...